A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel

9.7K views

⸱

DOI:

10.3791/57383

⸱

May 14th, 2018

 ,  , 

Corresponding Authors: Neil J. Ganem <nganem@bu.edu>

In This Article

Summary

Live-cell imaging provides a wealth of information on single cells or whole populations that is unattainable by fixed cell imaging alone. Here, live-cell imaging protocols to assess cell fate decisions following treatment with the anti-mitotic drug paclitaxel are described.

Abstract

Live-cell imaging is a powerful technique that can be used to directly visualize biological phenomena in single cells over extended periods of time. Over the past decade, new and innovative technologies have greatly enhanced the practicality of live-cell imaging. Cells can now be kept in focus and continuously imaged over several days while maintained under 37 °C and 5% CO2 cell culture conditions. Moreover, multiple fields of view representing different experimental conditions can be acquired simultaneously, thus providing high-throughput experimental data. Live-cell imaging provides a significant advantage over fixed-cell imaging by allowing for the direct visualization and temporal quantitation of dynamic cellular events. Live-cell imaging can also identify variation in the behavior of single cells that would otherwise have been missed using population-based assays. Here, we describe live-cell imaging protocols to assess cell fate decisions following treatment with the anti-mitotic drug paclitaxel. We demonstrate methods to visualize whether mitotically arrested cells die directly from mitosis or slip back into interphase. We also describe how the fluorescent ubiquitination-based cell cycle indicator (FUCCI) system can be used to assess the fraction of interphase cells born from mitotic slippage that are capable of re-entering the cell cycle. Finally, we describe a live-cell imaging method to identify nuclear envelope rupture events.

Introduction

Anti-mitotic drugs have long been used in the chemotherapeutic regimens of various types of solid tumors and often show great efficacy1,2,3. Mechanistically, these drugs disrupt normal mitotic progression and promote mitotic arrest in rapidly proliferating cancer cells. However, cell fate in response to mitotic arrest is highly variable: while a fraction of cells undergoes cell death directly from mitosis, others exit out of mitosis and return to interphase as tetraploid cells (a process termed mitotic slippage)4,5

Access restricted. Please log in or start a trial to view this content.

Protocol

This protocol focuses on using the non-transformed and chromosomally stable retinal pigmented epithelial (RPE-1) cell line for live-cell imaging experiments. However, this protocol can be adapted to any adherent cell line so long as cell culture conditions are adjusted as necessary. All procedures must adhere to institutional biosafety and ethical guidelines and regulations.

1. Preparing Cells for Live-cell Imaging

  1. Use freshly thawed and early passage RPE-1 cells expressing either human histone H2B fused to a fluorescent protein (e.g. H2B-GFP), or the FUCCI system (a detailed protocol on how to generate FUCCI-ex....

Access restricted. Please log in or start a trial to view this content.

Results

Using the protocol described above, RPE-1 cells expressing H2B-GFP were treated with an anti-mitotic or vehicle control (DMSO) and analyzed by live-cell imaging. Analysis revealed that 100% of control mitotic RPE-1 cells initiated anaphase an average of 22 min after entering mitosis (Figure 1A, 1D). By contrast, RPE-1 cells treated with paclitaxel exhibited a profound mitotic arrest lasting several hours (Figure 1D

Access restricted. Please log in or start a trial to view this content.

Discussion

The most critical aspect of long-term live-cell imaging is ensuring the health of the cells being imaged. It is essential that cells be exposed to minimal extraneous environmental stressors, such as substandard conditions regarding temperature, humidity, and/or CO2 levels. It is also important to limit photodamage from fluorescent excitation illumination, as imaging stress is known to affect cell behavior50. Limiting photodamage can be achieved in multiple ways as detailed elsewhere

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

AFB, MAV and NJG would like to thank Ryan Quinton for comments on the manuscript and Adrian Salic for the TDRFP-NLS construct. AFB and MAV are funded by the NIGMS Biomolecular Pharmacology Training Grant 5T32GM008541. NJG is a member of the Shamim and Ashraf Dahod Breast Cancer Research Laboratories and is supported by NIH grants GM117150 and CA-154531, the Karin Grunebaum Foundation, the Smith Family Awards Program, the Searle Scholars Program, and the Melanoma Research Alliance.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
phenol red-free, DMEM:F12 mediaHycloneSH3027202
10% fetal bovine serum (FBS)Gibco10438026
100 IU/ml penicillin, and 100 mg/ml streptomycin.Gibco15070063
PBSGibco10010049
0.25% Trypsin/EDTAGemini50-753-3104
12-well glass bottomed imaging dishCellvisP12-1.5H-N
PaclitaxelTSZ ChemRS036
Dimethyl Sulfoxide (DMSO)SigmaNC0215085
Environmental ChamberIn Vivo Scientific
5% CO2AirgasZ03NI7432000201
15 mL Conical TubesFisherbrand05-539-12
10 cm polystyrene tissue culture platesFalcon08772E
10 mL Disposable Serological PipetteFisherbrand4488
5804R 15 amp CentrifugeEppendorf97007-370
1000 microliters PipetteGilsonPipetman Classic
20 microliters PipetteGilsonPipetman Classic
p1000 Pipette TipsSharpp1126
p20 Pipette TipsSharpP1121
RPE-1 CellsATCCCRL-4000
Incubator Galaxy 170SEppendorfCO17011005
Pipette BoyIntegra156401
HemacytometerFisher Scientific0267110
Nikon Ti-E-PFS Inverted Microscope for Live Cell ImagingMicro Video Instruments, Inc.MEA53100
Prior X-Y Stage System and White Light LED IlluminatorMicro Video Instruments, Inc.500-H117P1N4
Prior Proscan 3 Controller XYZ with EncodersMicro Video Instruments, Inc.500-H31XYZE
Andor Digital CameraMicro Video Instruments, Inc.D10NLC
Nikon NIS Elements AR SoftwareMicro Video Instruments, Inc.MQS31000
SOLA LED Illuminator for FluorescenceMicro Video Instruments, Inc.SOLA-E
InVivo Environmental Chamber with CO2 Flow ControlMicro Video Instruments, Inc.Ti-IVS-100
Ti-ND6-PFS Perfect Focus Motorized NosepieceMicro Video Instruments, Inc.MEP59391
Ti-C System Condenser TurretMicro Video Instruments, Inc.MEL51000
Ti-C LWD LWD Lens Unit for System Condenser TurretMicro Video Instruments, Inc.MEL56200
Te-C LWD Ph1 ModuleMicro Video Instruments, Inc.MEH41100
CFI Plan Fluor DLL 10X Objectivena 0.3 wd 16mmMicro Video Instruments, Inc.MRH10101
CFI Super Plan Fluor ELWD 20xc ADM ObjectiveMicro Video Instruments, Inc.MRH48230

References

  1. van Vuuren, R. J., Visagie, M. H., Theron, A. E., Joubert, A. M. Antimitotic drugs in the treatment of cancer. Cancer Chemother Pharmacol. 76 (6), 1101-1112 (2015).
  2. Chan, K. S., Koh, C. G., Li, H. Y. Mitosis-targeted anti-cancer therapies: where they stand. Cell Death Dis. 3

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Paclitaxel TreatmentCell Fate AssessmentMitotic SlippageNuclear Envelope RuptureFUCCI SystemH2B-GFP LabelingPhase-contrast MicroscopyLong-term ImagingSingle Cell Analysis